These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18096675)

  • 1. Hepatic synthesis and urinary elimination of acetaminophen glucuronide are exacerbated in bile duct-ligated rats.
    Villanueva SS; Ruiz ML; Ghanem CI; Luquita MG; Catania VA; Mottino AD
    Drug Metab Dispos; 2008 Mar; 36(3):475-80. PubMed ID: 18096675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethynylestradiol increases expression and activity of rat liver MRP3.
    Ruiz ML; Villanueva SS; Luquita MG; Vore M; Mottino AD; Catania VA
    Drug Metab Dispos; 2006 Jun; 34(6):1030-4. PubMed ID: 16554369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic and extrahepatic synthesis and disposition of dinitrophenyl-S-glutathione in bile duct-ligated rats.
    Villanueva SS; Ruiz ML; Soroka CJ; Cai SY; Luquita MG; Torres AM; Sánchez Pozzi EJ; Pellegrino JM; Boyer JL; Catania VA; Mottino AD
    Drug Metab Dispos; 2006 Aug; 34(8):1301-9. PubMed ID: 16679389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effect of spironolactone administration on ethynylestradiol-induced cholestasis in the rat: involvement of up-regulation of multidrug resistance-associated protein 2.
    Ruiz ML; Villanueva SS; Luquita MG; Ikushiro S; Mottino AD; Catania VA
    Drug Metab Dispos; 2007 Nov; 35(11):2060-6. PubMed ID: 17686906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shift from biliary to urinary elimination of acetaminophen-glucuronide in acetaminophen-pretreated rats.
    Ghanem CI; Ruiz ML; Villanueva SS; Luquita MG; Catania VA; Jones B; Bengochea LA; Vore M; Mottino AD
    J Pharmacol Exp Ther; 2005 Dec; 315(3):987-95. PubMed ID: 16109740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of repeated administration with subtoxic doses of acetaminophen to rats on enterohepatic recirculation of a subsequent toxic dose.
    Ghanem CI; Ruiz ML; Villanueva SS; Luquita M; Llesuy S; Catania VA; Bengochea LA; Mottino AD
    Biochem Pharmacol; 2009 May; 77(10):1621-8. PubMed ID: 19426699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice.
    Tanaka Y; Kobayashi Y; Gabazza EC; Higuchi K; Kamisako T; Kuroda M; Takeuchi K; Iwasa M; Kaito M; Adachi Y
    Am J Physiol Gastrointest Liver Physiol; 2002 Apr; 282(4):G656-62. PubMed ID: 11897625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease.
    Lickteig AJ; Fisher CD; Augustine LM; Aleksunes LM; Besselsen DG; Slitt AL; Manautou JE; Cherrington NJ
    Drug Metab Dispos; 2007 Oct; 35(10):1970-8. PubMed ID: 17640958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered regulation of hepatic efflux transporters disrupts acetaminophen disposition in pediatric nonalcoholic steatohepatitis.
    Canet MJ; Merrell MD; Hardwick RN; Bataille AM; Campion SN; Ferreira DW; Xanthakos SA; Manautou JE; A-Kader HH; Erickson RP; Cherrington NJ
    Drug Metab Dispos; 2015 Jun; 43(6):829-35. PubMed ID: 25788542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatobiliary excretion of acetaminophen glutathione conjugate and its derivatives in transport-deficient (TR-) hyperbilirubinemic rats.
    Chen C; Hennig GE; Manautou JE
    Drug Metab Dispos; 2003 Jun; 31(6):798-804. PubMed ID: 12756215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene.
    Manautou JE; de Waart DR; Kunne C; Zelcer N; Goedken M; Borst P; Elferink RO
    Hepatology; 2005 Nov; 42(5):1091-8. PubMed ID: 16250050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of multidrug resistance protein 3 in rat liver is associated with altered vectorial excretion of acetaminophen metabolites.
    Slitt AL; Cherrington NJ; Maher JM; Klaassen CD
    Drug Metab Dispos; 2003 Sep; 31(9):1176-86. PubMed ID: 12920174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of impaired biliary excretion of acetaminophen glucuronide after acute phenobarbital treatment or phenobarbital pretreatment.
    Xiong H; Suzuki H; Sugiyama Y; Meier PJ; Pollack GM; Brouwer KL
    Drug Metab Dispos; 2002 Sep; 30(9):962-9. PubMed ID: 12167560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of the expression of adenosine triphosphate-binding cassette transporters associated with bile acid and cholesterol transport in the rat liver and intestine during cholestasis.
    Kamisako T; Ogawa H
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1429-34. PubMed ID: 16105132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of acetaminophen on expression and activity of rat liver multidrug resistance-associated protein 2 and P-glycoprotein.
    Ghanem CI; Gómez PC; Arana MC; Perassolo M; Ruiz ML; Villanueva SS; Ochoa EJ; Catania VA; Bengochea LA; Mottino AD
    Biochem Pharmacol; 2004 Aug; 68(4):791-8. PubMed ID: 15276087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression of MRP2, MRP3 and UGT2B1 in the liver affects the disposition of morphine and its glucuronide conjugate in a rat model of cholestasis.
    Hasegawa Y; Kishimoto S; Takahashi H; Inotsume N; Takeuchi Y; Fukushima S
    J Pharm Pharmacol; 2009 Sep; 61(9):1205-10. PubMed ID: 19703370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of Mrp2 in hepatic and intestinal disposition of dinitrophenyl-S-glutathione in partially hepatectomized rats.
    Villanueva SS; Ruiz ML; Luquita MG; Sánchez Pozzi EJ; Catania VA; Mottino AD
    Toxicol Sci; 2005 Mar; 84(1):4-11. PubMed ID: 15590889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the role of multidrug resistance-associated protein (Mrp) 3 and Mrp4 in hepatic basolateral excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in Abcc3-/- and Abcc4-/- mice.
    Zamek-Gliszczynski MJ; Nezasa K; Tian X; Bridges AS; Lee K; Belinsky MG; Kruh GD; Brouwer KL
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1485-91. PubMed ID: 16988054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR(-) rats.
    Xiong H; Turner KC; Ward ES; Jansen PL; Brouwer KL
    J Pharmacol Exp Ther; 2000 Nov; 295(2):512-8. PubMed ID: 11046083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glucagon-like peptide 2 on hepatic, renal, and intestinal disposition of 1-chloro-2,4-dinitrobenzene.
    Villanueva SS; Perdomo VG; Ruiz ML; Rigalli JP; Arias A; Luquita MG; Vore M; Catania VA; Mottino AD
    Drug Metab Dispos; 2012 Jul; 40(7):1252-8. PubMed ID: 22453052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.